GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evotec SE (XTER:EVT) » Definitions » Days Sales Outstanding

Evotec SE (XTER:EVT) Days Sales Outstanding : 52.68 (As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Evotec SE Days Sales Outstanding?

Evotec SE's average Accounts Receivable for the three months ended in Dec. 2023 was €116.2 Mil. Evotec SE's Revenue for the three months ended in Dec. 2023 was €201.3 Mil. Hence, Evotec SE's Days Sales Outstanding for the three months ended in Dec. 2023 was 52.68.

The historical rank and industry rank for Evotec SE's Days Sales Outstanding or its related term are showing as below:

XTER:EVT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.75   Med: 62.18   Max: 96.99
Current: 96.99

During the past 13 years, Evotec SE's highest Days Sales Outstanding was 96.99. The lowest was 44.75. And the median was 62.18.

XTER:EVT's Days Sales Outstanding is ranked worse than
72.17% of 999 companies
in the Drug Manufacturers industry
Industry Median: 72.38 vs XTER:EVT: 96.99

Evotec SE's Days Sales Outstanding declined from Sep. 2022 (58.40) to Dec. 2023 (52.68).


Evotec SE Days Sales Outstanding Historical Data

The historical data trend for Evotec SE's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evotec SE Days Sales Outstanding Chart

Evotec SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.40 61.99 64.96 73.04 62.37

Evotec SE Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.40 54.21 99.45 78.23 52.68

Competitive Comparison of Evotec SE's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Evotec SE's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evotec SE's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Evotec SE's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Evotec SE's Days Sales Outstanding falls into.



Evotec SE Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Evotec SE's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (168.653 + 98.396) / 2 ) / 781.426*365
=133.5245 / 781.426*365
=62.37

Evotec SE's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (134.038 + 98.396) / 2 ) / 201.313*365 / 4
=116.217 / 201.313*365 / 4
=52.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evotec SE  (XTER:EVT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Evotec SE Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Evotec SE's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Evotec SE (XTER:EVT) Business Description

Address
Essener Bogen 7, Manfred Eigen Campus, Hamburg, DEU, 22419
Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as foundations, and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes & its complications, pain, inflammation, oncology, infectious diseases, respiratory & fibrosis, rare disease, and women's health. Its business segments are EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programs and assets, both internally and through academic collaborations. The majority of its revenue is derived from the EVT Execute segment.
Executives
Dr. Werner Lanthaler Board of Directors

Evotec SE (XTER:EVT) Headlines